AI Market Mood: Stock Dashboard
TFX
Fundamental
Company: Teleflex Incorporated
Sector: Healthcare
Industry: Medical Instruments & Supplies
Country: USA
Exchange: NYSE
Index: -
P/E: -
EPS (ttm): -7.36
Insider Own: 0.78%
Shs Outstand: 44.19M
Perf Week: -4.31%
Market Cap: 4.58B
Forward P/E: 7.38
EPS next Y: 14.05
Insider Trans: 0.00%
Shs Float: 43.85M
Perf Month: 0.68%
Enterprise Value: 6.99B
PEG: 2.30
EPS next Q: 3.76
Inst Own: 105.99%
Short Float: 4.99%
Perf Quarter: -6.94%
Income: -327.97M
P/S: 1.44
EPS this Y: 0.05%
Inst Trans: 3.06%
Short Ratio: 2.57
Perf Half Y: -14.61%
Sales: 3.19B
P/B: 1.20
EPS next Y Percentage: 0.25%
ROA: -4.27%
Short Interest: 2.19M
Perf YTD: -14.99%
Book/sh: 86.48
P/C: 12.43
EPS next 5Y: 3.21%
ROE: -7.90%
52W High: 180.58 -42.55%
Perf Year: -38.10%
Cash/sh: 8.34
P/FCF: 17.34
EPS past 3/5Y: -47.52% -31.49%
ROIC: -5.05%
52W Low: 100.18 3.56%
Perf 3Y: -57.81%
Dividend Est.: 1.35 (1.30%)
EV/EBITDA: 8.22
Sales past 3/5Y: 2.74% 3.26%
Gross Margin: 53.86%
Volatility W: 3.47%
Volatility M: 2.98%
Perf 5Y: -74.46%
Dividend TTM: 1.36 (1.31%)
EV/Sales: 2.19
EPS Y/Y TTM: -245.18%
Oper. Margin: 17.79%
ATR (14): 3.52
Perf 10Y: -21.78%
Dividend Ex-Date: Nov 14, 2025
Quick Ratio: 1.53
Sales Y/Y TTM: 5.43%
Profit Margin: -10.28%
RSI (14): 41.07
Recom: 2.86
Dividend Gr. 3/5Y: 0.00% 0.00%
Current Ratio: 2.57
EPS Q/Q: -491.46%
SMA20: -0.81%
Beta: 0.90
Target Price: 128.22
Payout: 91.92%
Debt/Eq: 0.72
Sales Q/Q: 19.45%
SMA50: -9.13%
Rel Volume: 0.79
Prev Close: 104.54
Employees: 14100
LT Debt/Eq: 0.70
Earnings: Nov 06 BMO
SMA200: -13.21%
Avg Volume: 851.91K
Price: 103.75
IPO: Apr 24, 1967
Option/Short: Yes / Yes
EPS/Sales Surpr.: 7.63% 0.01%
Trades:
Volume: 676,018
Change: -0.76%
Technical:
Latest News:
Wells Fargo Sticks to Its Hold Rating for Teleflex (TFX) | Markets Insider neutral
TFX TFX
Summary: Analysts from Wells Fargo, Needham, and JMP Securities recently provided ratings on Teleflex (TFX) with varying perspectives. Teleflex reported a quarterly revenue of $773.91 million, slightly higher than the previous year, but with a lower net profit. The company provides medical technology products focused on improving patient outcomes and safety.
Full article2024-05-03T18:12:46Z